ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Orchid Cellmark (MM)

Orchid Cellmark (MM) (ORCH)

2.79
0.00
( 0.00% )
Updated: 20:00:00

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.79
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
2.79
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ORCH Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 23.145
(387.26%)
23M
XLOXilio Therapeutics Inc
$ 1.45
(126.92%)
29.61M
NXLNexalin Technologies Inc
$ 1.71
(119.23%)
6.56M
BDRXBiodexa Pharmaceuticals PLC
$ 1.57
(82.77%)
83.83M
CEROCERo Therapeutics Holdings Inc
$ 2.88
(76.69%)
19.03M
BOLDBoundless Bio Inc
 14.72
(-75.45%)
554.57k
PMECPrimech Holdings Ltd
$ 1.3905
(-64.16%)
6.7M
GMDAGamida Cell Ltd
$ 0.0352
(-40.54%)
76.56M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.2178
(-33.37%)
16.68M
NKLANikola Corporation
$ 1.03
(13.30%)
139.41M
BDRXBiodexa Pharmaceuticals PLC
$ 1.57
(82.77%)
83.83M
GMDAGamida Cell Ltd
$ 0.0352
(-40.54%)
76.56M
MARAMarathon Digital Holdings Inc
$ 22.995
(4.19%)
71.6M
AKANAkanda Corporation
$ 0.1486
(-9.88%)
68.21M

ORCH Discussion

View Posts
Renee Renee 9 years ago
That is fantastic, Rubs. I am delighted for you. $4 a share!!
👍️0
rubs1 rubs1 9 years ago
I received my check for about $4 per share the other day.
👍️0
rubs1 rubs1 9 years ago
I received an email last night that indicated that they 'expect' to distribute the settlement in the next 30 days.
👍️0
rubs1 rubs1 9 years ago
My recollection was that they projected the payment of $4 per share. Not sure if that changes with different numbers of people/shares that signed up. I only had 1K shares.
👍️0
Santa Barbara Broker Santa Barbara Broker 9 years ago
Renee..ORCH is an interesting choice here...

Hmmm, anywhere we can talk? Two symbols...FLY & BBEP...
👍️0
Renee Renee 9 years ago
Excellent. Thanks for the update, Rubs!!!

I hope they're generous.
👍️0
rubs1 rubs1 9 years ago
I received an email from the attorneys, they said they are awaiting approval from the court for dispersal of the funds.
👍️0
rubs1 rubs1 9 years ago
The ruling occurred 6/30/14, and we were waiting for the defendants to file a contention.
👍️0
Renee Renee 9 years ago
I only post FINRA actions without owning any of the stocks. I hope you'll post the Court Ruling / Order when it occurs.
👍️0
rubs1 rubs1 9 years ago
I do not know if you were still holding those shares, but there was a class action suit that is almost final. Here is the note I got from the attorney running the suit...as to status.

We are currently waiting on an order from the Court to allow us to disburse.
👍️0
Renee Renee 12 years ago
ORCH delisted:

http://nasdaqtrader.com/Trader.aspx?id=TradeHalts

12/16/2011 08:10:21 ORCH Orchid Cellmark Inc. NASDAQ D 12/19/2011
👍️0
mlkrborn mlkrborn 12 years ago
ORCH $2.71 ; offer to buy by Laboratory Corp of America (LH) announced it is extending its cash offer for all outstanding shares of Orchid Cellmark (ORCH) 2.73 -0.03 : Co announced that LabCorp is extending until 5:00 p.m., New York City time LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark (ORCH). On May 17, 2011, LabCorp received a request from the Federal Trade Commission, or the FTC, for additional information under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the acquisition of Orchid by LabCorp. LabCorp previously extended its tender offer to November 14, 2011.
👍️0
surf1944 surf1944 13 years ago
http://www.nasdaq.com/asp/holdings.asp?symbol=ORCH&selected=ORCH&FormType=Institutional
👍️0
surf1944 surf1944 13 years ago
http://www.secform4.com/insider-trading/1107216.htm
👍️0
surf1944 surf1944 14 years ago
7:05AM Orchid Cellmark discusses FBI re-evaluation of requirements for outsourcing dna forensic testing to private laboratories (ORCH) 1.89 : Co issued press release saying it "praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories. Current FBI quality assurance policies call for public labs to review 100% of private lab forensic DNA work before the results are uploaded into the National DNA Index System (NDIS)... "Eliminating this burden would greatly enhance the efficiency of public-private partnerships for DNA testing. It would also provide a tremendous opportunity to not only cost-effectively eliminate the current DNA testing backlog but also maintain zero backlog going forward as has been achieved in the United Kingdom, where changes to the rules governing public-private partnerships for DNA testing have already enabled significant efficiencies." On March 23, the FBI stated that it "is currently re-evaluating existing policies, standards, and protocols, including requirements for outsourcing DNA analysis to private laboratories and review of their results by public law enforcement laboratories"... Orchid Cellmark is one of the largest providers of forensic DNA testing services."
👍️0
ScovilleUnits ScovilleUnits 16 years ago
Hummm?

ORCH: Volume Spike; 40% > 20-adsv, Stock +12.08%

Friday , January 18, 2008 12:11ET

This is the 1st VOLUME alert for ORCH in the past 7 calendar days.

Trading for Orchid Cellmark Inc. (NASDAQ NM: ORCH) has been heavier than usual in today's session. By 12:10 ET, the stock had already traded 80,146 shares via 294 trades. The cumulative volume is 40.44% above its 20-day average of 57,067. Normally the stock experiences around 295 individual trades per session.

So far, today's volume surge has caused a net rise in ORCH's stock price. At the time of this alert, the stock was trading at $5.660, up $0.610 (+12.08%).

One year ago, the Company's shares closed at $3.860. The price has gained more than 46 percent since then.

Over the last 10 trading session ORCH has traded in a range between $4.899 and $5.100 and is currently trading 20.62% below its 52-week high of $7.130 set on April 11,2007 and 57.22% above its 52-week low of $3.600 from January 26,2007.

In the previous 3 sessions, ORCH trading has displayed a mixed trend. Closing results have been as follows:

January 17, 2008 --- closed at $5.050 up $0.050 (+1.00%) on 75,810 shares
January 16, 2008 --- closed at $5.000 down $0.010 (-0.20%) on 55,450 shares
January 15, 2008 --- closed at $5.010 even for the day on 68,780 shares

The Company has not released news in the past 30 days

http://www.knobias.com/story.htm?eid=3.1.26a2a2bd13f8b14c97b2d52c428d1db1d3f4a8fcb2429ce3a1e03ee1473f2cfb
👍️0
Jedtailedhawk Jedtailedhawk 18 years ago
Forensic science is still in the dark ages. You know what they say, "it takes a whole generation to change." Why? Because the encockroached beurocrats have to retire - they don't want to make any waves on their citizen-sponsored gravy train.

Recently I read about a police "sniffer" dog trained for finding evidence that turned on it's owner and attacked the SOB. What's the matter, too much whipping? Evidence wasn't there? That is so old school.

Because of the multitude of conflicts of interests that exist in our legal system, from lawyers and judges being fellow alumni, to public defenders being C- barely graduated attorneys, to detectives and prosecutors selectively cherry-picking evidence, the only hope for a resurgence of democracy in this country is double-blind collection of, and interpretation of, evidence. What this would entail is premature and wrong conclusions may still occur, but can't be as easily covered up. Farm out the forensic DNA work to a competent, independent private firm with an impeccable reputation.

After all, if you were pulled over in the middle of the night and bloodstains from some parking lot brawl were on your car, and you brushed against them, what testing would Mr. Policia do first? Look for evidence AGAINST you. Defense lawyers and judges are going to have to accept this fact. Too many innocent people have gone to jail.

Furthermore: What about the nymphomaniac that gets pregnant? She was fertilized just yesterday, but had sex with another man today, and claims it was rape. The swab test confirms it: there was sex today. What happens nine months later? Some po mothafuka poundin his fists away at the cell walls, sayin' der ain't no justice man.
👍️0
vieuxblue vieuxblue 18 years ago
Bro, very helpful post. Your post and Paula's subsequent response have made me a bit more negative on Orchid's future, although I think government will always need a certified, reliable company to handle DNA assays.
👍️0
hasbro123 hasbro123 18 years ago
Forensic Science Professionals Applaud U.S. Senate Support
CSIs, Medical Examiners and Crime Lab Directors Praise Senator Richard Shelby
WASHINGTON, DC -- (MARKET WIRE) -- July 21, 2006 -- The Consortium of Forensic Science Organizations (www.theCFSO.org) applauds the efforts of Senator Richard Shelby (R-AL) and the U.S. Senate for supporting critical funding for all aspects of forensic science.

State and local crime laboratories are an integral part of the criminal justice system. Recent years have seen a dramatic increase in the demand on the labs for forensic testing of a variety of evidence types, but funding has not kept pace. Crime lab backlogs cause significant delays in evidentiary analysis, resulting in delays in the investigation and solving of crimes, as well as delays in the courts. At last check, the largest 50 laboratories in the U.S. more than doubled their backlogs of unprocessed evidence.

The forensics community praises Senator Shelby for his understanding of the current situation in all forensic areas, including controlled substances, latent prints and DNA.

The issue of funding forensic science is currently being debated in Congress, as part of the federal government's criminal justice budget for fiscal year 2007. The U.S. Senate Appropriations Committee has approved $18 million for the Paul Coverdell Forensic Science Act in the Senate Commerce, Justice, and Science Appropriations bill and an additional $175 million for DNA.

"Senator Richard Shelby, Chair of the Commerce, Justice, and Science Appropriations Subcommittee, is a great supporter of the forensics community," says Joseph Polski, Chair, Consortium of Forensic Science Organizations. "He understands that it is critical that funding support ALL aspects of forensic science, because major crimes are solved by a broad spectrum of forensic disciplines," stated Polski.

"In Washington State, we have experienced a massive increase in the number of forensic cases. Adequate crime lab funding is a constant battle," says Dr. Barry Logan, Forensic Science Laboratory Services, Washington State Patrol. "Forensic funding is a government responsibility at all levels."

"Funding for our crime labs is a national issue at a critical stage. What you see on television is not reality," says Barry A. J. Fisher, Crime Lab Director for the Los Angeles County Sheriff Department. "Crime labs are running large backlogs and simply don't have resources to get results out in a timely basis. This federal money will be a great help," he stated.

👍️0
hasbro123 hasbro123 18 years ago
Da bushie will be pointless after november.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-20-2006/0004400739&...
👍️0
hasbro123 hasbro123 18 years ago
I can't disagree with you at this point but DNA testing is here to stay and it's in the early stages.................it's a rotten deal to be in this position when kelly had stated that profitability was around the corner...........i have taken a good hit but life goes on.
have you read the info given by the guy who started this board...........it's kind of ironic.
👍️0
locobio locobio 18 years ago
The company must be sold to a larger entity, it seems to me. CEO did say in last call that he felt there was sufficient cash on hand to run for the near future without new financing. I'm hoping for this Bologna to clean up the balance sheet and slim the losses, then sell by spring. Willing to give him a chance, as the labs are good ones and the business they do is real and not going to go away completely. The next six months will tell for me whether I feel like staying or not. At this point though it's dead money, with pure speculation going forward, but I don't need to take a loss.
👍️0
XenaLives XenaLives 18 years ago
My thoughts on Orchid remain the same. They needed profitability several years ago to make the business model work. Now it looks like they won't turn the corner until desktop computers are going into hospitals and police departments that will do the lab work that gets farmed out to Orchid.

The window of opportunity will close on this one.

Just my personal opinion, of course.


👍️0
hasbro123 hasbro123 18 years ago
Vieux.......the NOL is limited.
It begins to expire this year due to rules regarding the cellmark deal.
Unfortunately they may lose a good deal of that NOL.
From the last filing...............

As of December 31, 2005, our net operating loss, or NOL, carryforwards were approximately $234 million and approximately $194 million for Federal and state income tax purposes, respectively. Our Federal and state NOL carryforwards begin to expire in 2006. Utilization of our NOL carryforwards to offset future taxable income, if any, may be substantially limited due to “change of ownership” provisions in the Tax Reform Act of 1986, or the Act. The Act provides for a limitation on the annual use of NOL carryforwards and research and development credits following certain ownership changes, as defined by the Act, which could significantly limit our ability to utilize
these carryforwards and research and development credits. We have determined that an ownership change, as defined by the Act, occurred in 1999. Approximately $36 million of NOL carryforwards is limited due to this ownership change. Additionally, because US tax laws limit the time during which these carryforwards may be applied against future taxes, we may not be able to take full advantage of these attributes for Federal income tax purposes. The NOL carryforwards subject to expiration through the year 2019 is approximately $32 million. We may have experienced other ownership changes, as defined by the Act, as a result of past financings and may experience others in connection with future financings. Accordingly, our ability to utilize the aforementioned Federal NOL carryforwards may be further limited in the future.

The filing may have more bark then bite though...........losing only 32 million thru 2019 isn't that terrible IMHO.

👍️0
vieuxblue vieuxblue 18 years ago
Hasbro,

I agree in main with your post. However, Orchid has two items of value to a buyer:

1. An existing testing system and operations network, and

2. Tax losses that would be purchased in an acqusition, reducing the purchase price.

I'm not a financial analyst, but that might be enough to tip the scales.
👍️0
hasbro123 hasbro123 18 years ago
Some info on DNA testing.................

http://www.insideindianabusiness.com/newsitem.asp?ID=18808
👍️0
hasbro123 hasbro123 18 years ago
Yahoo down over 4 bucks after hours.
with the destruction of the message boards i don't doubt that ad clicks go down as fewer eyes are watching.
👍️0
hasbro123 hasbro123 18 years ago
I think the whole thing rests on whether DNA testing is something that can have revs and margins high enough without multiple rev streams.
If not then a sale is the only way to go.
If they go and try to expand the biz and testing is only a segment i have to wonder where they get the money?
Of course it would involve dilution but who would buy shares of this and what could they expand into that would create good revs and margins immeadiately?

Sell it...........or merge..........i can't see how they run it as it stands now.
If sold or merge occurs i would not expect any great premium based on current situation as they are over 300 million in the hole and that debt would be absorbed by whoever buys or nerges.
Of course the board and management will do very well.
👍️0
vieuxblue vieuxblue 18 years ago
Jed thanks for the referral to the new hotel. Since they renovated the old place, you can't find the rooms anymore!

So, here's my last post from the old hotel:

Orchid's SP is at historic pre-split lows. There is unlikely to be good news for at least 6-9 months, perhaps longer. The new CEO is cleaning house and is in the process of finding a new executive team to run the company. It has about one year of cash left to run the business and is currently (and has always) operated at a loss.

There is no reason therefore that, especially in a reverse speculative market (that is, one in which speculation is punished), that Orchid's SP will not continue to decline for the next 6 -9 months. Over that time, there may be a better "buying opportunity". So why not sell now and buy back if you believe the company has a decent chance at long-term recovery, which it may indeed have, assuming that the board has, in Bologna, finally found someone who can lead? My only reason for holding my shares is that I hate to rack up a large loss in my portfolio. But that's not a good reason for holding.

I would appreciate pro/con comments.
👍️0
hasbro123 hasbro123 18 years ago
Hi my name is hasbro and i'm a wanker.
Applause, applause, clap, clap.
HI HASBRO!!!!

Tis better to have wanked and lost then never to have wanked at all!

👍️0
Jedtailedhawk Jedtailedhawk 18 years ago
Maybe we have should join Wankers Anonymus.... WA!
👍️0
hasbro123 hasbro123 18 years ago
It's in a holding pattern.......so there is plenty of time for wankers to wank.
👍️0
Jedtailedhawk Jedtailedhawk 18 years ago
Well the whale happens to like hovering at the $2.50 for now. It is just a matter of how patient you are now. It's still way to early to take any tax losses, so take yer shoes off, set a spell, and all come back now, here?
👍️0
justastock justastock 18 years ago
Nice pick here >

http://www.investorshub.com/boards/read_msg.asp?message_id=11510531

Justa
👍️0
lugan lugan 18 years ago
I watch it. Feel free to comment.
👍️0
justastock justastock 18 years ago
Anyone still following this one, covering it on this board >

http://www.investorshub.com/boards/read_msg.asp?message_id=11510531

Justa.
👍️0
Doug Hauser Doug Hauser 18 years ago
Gosh the ol Firewall let her in. Yah never know. Look this is great I am a player and someday maybe I can suggest we bring in some value added to our clients. Who Knows? Any way I like it. too bad this equity is trashed a bit but since I am ttrader will make lemonaid

👍️0
Trade Ideas Trade Ideas 18 years ago
Thanks! Here's a bit more:

IH Forum:
http://www.investorshub.com/boards/board.asp?board_id=1530

Our blog too:
http://marketmovers.blogspot.com/
👍️0
Doug Hauser Doug Hauser 18 years ago
Damm good piece o work. Just noticed it and will be bookmarked. You da man.
👍️0
Doug Hauser Doug Hauser 18 years ago
Man o man all the little squid up and vanished. O well. I dont think forensics is done quite yet. But I could be wrong.
👍️0
Doug Hauser Doug Hauser 18 years ago
LOL what a difference a day makes. Hah pretty soon they'll be swamping the offer with bids. 4.58 what a joke I wont soon forget


👍️0
Doug Hauser Doug Hauser 18 years ago
You might not want to tangle with me.
👍️0
Doug Hauser Doug Hauser 18 years ago
LOL you guys are my punching bag btc 4.58 done. Bring em on.
👍️0
Doug Hauser Doug Hauser 18 years ago
Added 4.61 thats the old .92 babee. Oh aint like she grand.
👍️0
lugan lugan 18 years ago
I think you've made a good buy. This should be a long term hold.
👍️0
Doug Hauser Doug Hauser 18 years ago
Lugan hey guy thx I am also not just BS ing I bouhgt 700 shares of orch today to buttress my opening 400. All done in last day and half. Sure hope she rallies.
👍️0
lugan lugan 18 years ago
Who's Luke? If you are referring to DNAG, a small spec position is ok. I do not expect any major moves up in the near future.
👍️0
Doug Hauser Doug Hauser 18 years ago
Luke what you think? Would you really load the boat here. She sure is cheap. Or do you perceive risk yet?
👍️0
Doug Hauser Doug Hauser 18 years ago
Of course I am familier asboot of yahoo fame was a great proponent I just never got that religion. too many fish in the sea.
👍️0
lugan lugan 18 years ago
I was not recommending it. Just wondered if you were familiar with the company per your interest in Orchid.
👍️0

Your Recent History

Delayed Upgrade Clock